These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 1686758)
1. Sigma-receptors: implication for the control of neuronal activity of nigral dopamine-containing neurons. Engberg G; Wikström H Eur J Pharmacol; 1991 Aug; 201(2-3):199-202. PubMed ID: 1686758 [TBL] [Abstract][Full Text] [Related]
2. Electrophysiological effects of selective sigma-receptor agonists, antagonists, and the selective phencyclidine receptor agonist MK-801 on midbrain dopamine neurons. Steinfels GF; Tam SW; Cook L Neuropsychopharmacology; 1989 Sep; 2(3):201-8. PubMed ID: 2571340 [TBL] [Abstract][Full Text] [Related]
3. Acute effects of sigma ligands on the electrophysiological activity of rat nigrostriatal and mesoaccumbal dopaminergic neurons. Zhang J; Chiodo LA; Wettstein JG; Junien JL; Freeman AS Synapse; 1992 Aug; 11(4):267-78. PubMed ID: 1323882 [TBL] [Abstract][Full Text] [Related]
5. N-substituted 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines and 3-phenylpiperidines: effects on central dopamine and sigma receptors. Wikström H; Andersson B; Elebring T; Svensson K; Carlsson A; Largent B J Med Chem; 1987 Dec; 30(12):2169-74. PubMed ID: 2824773 [TBL] [Abstract][Full Text] [Related]
6. Effects of intraperitoneal administration of apomorphine and the isomers of 3-(1-propyl-3-piperidinyl)phenol on the firing activity of substantia nigra dopamine neurons: comparison of agonist efficacies and development of acute tolerance. Meltzer LT; Christoffersen CL Neuropharmacology; 1988 Sep; 27(9):933-42. PubMed ID: 3185867 [TBL] [Abstract][Full Text] [Related]
7. GABAB-receptor activation alters the firing pattern of dopamine neurons in the rat substantia nigra. Engberg G; Kling-Petersen T; Nissbrandt H Synapse; 1993 Nov; 15(3):229-38. PubMed ID: 8278899 [TBL] [Abstract][Full Text] [Related]
8. An electrophysiological analysis of the actions of the 3-PPP enantiomers on the nigrostriatal dopamine system. Clark D; Engberg G; Pileblad E; Svensson TH; Carlsson A; Freeman AS; Bunney BS Naunyn Schmiedebergs Arch Pharmacol; 1985 Jun; 329(4):344-54. PubMed ID: 4033804 [TBL] [Abstract][Full Text] [Related]
9. Irreversible receptor inactivation reveals differences in dopamine receptor reserve between A9 and A10 dopamine systems: an electrophysiological analysis. Cox RF; Waszczak BL Brain Res; 1990 Nov; 534(1-2):273-82. PubMed ID: 1981482 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of substantia nigra dopamine cell firing by R(-)-N-n-propylnorapomorphine: electrophysiological and autoradiographic studies after regional inactivation of dopamine receptors by microinjection of N-ethoxycarbonyl-2-ethoxy-1,2-dihydroquinoline. Cox RF; Waszczak BL Brain Res; 1993 Jun; 613(1):32-42. PubMed ID: 8102308 [TBL] [Abstract][Full Text] [Related]
11. Effects of L-DOPA on nigral dopamine neurons and local field potential: comparison with apomorphine and muscimol. Xu D; Karain B; Brantley E; Shi WX J Pharmacol Exp Ther; 2011 May; 337(2):533-9. PubMed ID: 21330359 [TBL] [Abstract][Full Text] [Related]
12. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra. Huang KX; Bergstrom DA; Ruskin DN; Walters JR Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877 [TBL] [Abstract][Full Text] [Related]
13. Further characterization of the effects of BMY 14802 on dopamine neuronal activity. Zhang J; Chiodo LA; Freeman AS Synapse; 1993 Dec; 15(4):276-84. PubMed ID: 7908761 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the effects of the cholecystokinin-B receptor antagonist, PD 134308, and the cholecystokinin-A receptor antagonist, L-364,718, on dopamine neuronal activity in the substantia nigra and ventral tegmental area. Meltzer LT; Christoffersen CL; Serpa KA; Razmpour A Synapse; 1993 Feb; 13(2):117-22. PubMed ID: 8446920 [TBL] [Abstract][Full Text] [Related]
15. Responsiveness to 'autoreceptor' doses of apomorphine inversely correlated with the firing rate of dopaminergic A9 neurons: action of baclofen. Mereu G; Muntoni F; Calabresi P; Romani F; Boi V; Gessa GL Neurosci Lett; 1986 Apr; 65(2):161-6. PubMed ID: 3714103 [TBL] [Abstract][Full Text] [Related]
16. D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists. Huang KX; Walters JR J Pharmacol Exp Ther; 1992 Jan; 260(1):409-16. PubMed ID: 1530977 [TBL] [Abstract][Full Text] [Related]
17. Pertussis toxin lesions of the rat substantia nigra block the inhibitory effects of the gamma-hydroxybutyrate agent, S(-)HA-966 without affecting the basal firing properties of dopamine neurons. Shepard PD; Connelly ST Neuropsychopharmacology; 1999 Nov; 21(5):650-61. PubMed ID: 10516961 [TBL] [Abstract][Full Text] [Related]
18. Electrophysiological and pharmacological characterization of identified nigrostriatal and mesoaccumbens dopamine neurons in the rat. Clark D; Chiodo LA Synapse; 1988; 2(5):474-85. PubMed ID: 2903568 [TBL] [Abstract][Full Text] [Related]
19. Comparison between the pharmacology of dopamine receptors mediating the inhibition of cell firing in rat brain slices through the substantia nigra pars compacta and ventral tegmental area. Bowery B; Rothwell LA; Seabrook GR Br J Pharmacol; 1994 Jul; 112(3):873-80. PubMed ID: 7921615 [TBL] [Abstract][Full Text] [Related]
20. Neurophysiological investigation of effects of the D-1 agonist SKF 38393 on tonic activity of substantia nigra dopamine neurons. Carlson JH; Bergstrom DA; Weick BG; Walters JR Synapse; 1987; 1(5):411-6. PubMed ID: 2975067 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]